NCT03653520View on ClinicalTrials.gov

Conscious Sedation Efficacy of the MKO Melt (Midazolam, Ketamine, Ondansetron)

NACompletedINTERVENTIONAL
Enrollment

651

Participants

Timeline

Start Date

June 28, 2017

Primary Completion Date

November 2, 2017

Study Completion Date

November 4, 2017

Conditions
Cataract
Interventions
DRUG

Diazepam

5 or 10mg

DRUG

Tramadol

50mg or 100mg

DRUG

Ondansetron

1 or two tabs

DRUG

MKO melt

1 or 2 MKO melts

Trial Locations (1)

77030

Memorial Hermann Kirby Glen Surgery Center, Houston

All Listed Sponsors
lead

Avanti Anesthesia

OTHER

NCT03653520 - Conscious Sedation Efficacy of the MKO Melt (Midazolam, Ketamine, Ondansetron) | Biotech Hunter | Biotech Hunter